Atea Pharmaceuticals, Inc. insiders have been one-way buyers this past year: one person put roughly $51,000 into the stock and nobody sold at market prices.
Murphy Polly A. (Director) made the biggest buy, worth around $25,000.
Big money check: 125 institutions held AVIR as of Q2 2026, and funds were split between buying and selling. Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | Murphy Polly A. | Director | Buy | 6,100 | $4.17 | $25K | SEC |
| May 20, 2026 | Murphy Polly A. | Director | Buy | 6,100 | $4.17 | $25K | SEC |
| Jan 17, 2025 | BERGER FRANKLIN M | Director | Buy | 15,000 | $3.19 | $48K | SEC |
| Jan 17, 2025 | BERGER FRANKLIN M | Director | Buy | 10,000 | $3.36 | $34K | SEC |
| Jan 17, 2025 | BERGER FRANKLIN M | Director | Buy | 15,000 | $3.19 | $48K | SEC |
| Jan 17, 2025 | BERGER FRANKLIN M | Director | Buy | 10,000 | $3.36 | $34K | SEC |
| Dec 12, 2024 | BERGER FRANKLIN M | Director | Sell | 359,606 | $2.85 | $1.0M | SEC |
| Sep 19, 2024 | Sommadossi Jean-Pierre | CEO | Sell | 22,187 | $4.03 | $89K | SEC |
| Sep 19, 2024 | Sommadossi Jean-Pierre | CEO | Sell | 33,941 | $4.05 | $137K | SEC |
| Sep 19, 2024 | Sommadossi Jean-Pierre | CEO | Sell | 1,841 | $4.00 | $7K | SEC |
| Jun 21, 2024 | Polsky Bruce | Director | Sell | 17,544 | $3.49 | $61K | SEC |
| Jun 7, 2024 | Sommadossi Jean-Pierre | CEO | Sell | 1,006 | $4.00 | $4K | SEC |
| Feb 2, 2024 | Sommadossi Jean-Pierre | CEO | Sell | 56,910 | $3.85 | $219K | SEC |
| Feb 2, 2024 | Foster Wayne | Executive Officer | Sell | 12,477 | $3.84 | $48K | SEC |
| Feb 2, 2024 | Hammond Janet MJ | Executive Officer | Sell | 14,029 | $3.84 | $54K | SEC |
In the last 12 months Atea Pharmaceuticals, Inc. insiders made open-market purchases worth about $51,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in AVIR was filed on 2026-05-21.
125 investment managers reported holding AVIR in SEC Form 13F filings for Q2 2026.
No congressional trades in AVIR were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).